XML 23 R37.htm IDEA: XBRL DOCUMENT v3.3.1.900
Stock-Based Compensation (Details 2) - USD ($)
3 Months Ended
Oct. 31, 2015
Oct. 31, 2014
Jul. 31, 2015
Stock-Based Compensation      
Total unrecognized stock-based compensation expense, before income taxes, related to total nonvested stock options and stock awards (in dollars) $ 22,064,000    
Remaining weighted average period over which unrecognized stock-based compensation expense is expected to be recognized 26 months    
Stock-based awards, additional disclosure      
Deduction in income tax due to exercise of options and vesting of restricted stock (in dollars) $ 3,041,000 $ 4,198,000  
Increase in additional paid-in capital due to excess tax benefit on stock-based compensation expense (in dollars) $ 1,489,000 $ 2,473,000  
Restricted shares      
Number of Shares      
Nonvested stock awards at the beginning of the period (in shares) 343,519    
Granted (in shares) 161,923    
Cancelled (in shares) (522)    
Vested (in shares) (152,601)    
Nonvested stock awards at the end of the period (in shares) 352,319    
Weighted Average Fair Value      
Nonvested stock awards at the beginning of the period (in dollars per share) $ 32.77    
Granted (in dollars per share) 54.23    
Cancelled (in dollars per share) 31.81    
Vested (in dollars per share) 28.60    
Nonvested stock awards at the end of the period (in dollars per share) $ 44.44    
Stock options      
Weighted-Average Black-Scholes Option Valuation Assumptions      
Dividend yield (as a percent) 0.22% 0.25%  
Expected volatility (as a percent) 55.90% 33.90%  
Risk-free interest rate (as a percent) 1.41% 1.55%  
Expected lives 5 years 5 years  
Stock options, additional disclosure      
Weighted average fair value of all options granted (in dollars per share) $ 26.49 $ 11.54  
Aggregate intrinsic value of all options exercised (in dollars) $ 0 $ 2,420,000  
Number of Shares      
Outstanding at the beginning of the period (in shares) 107,500    
Granted (in shares) 15,000    
Outstanding at the end of the period (in shares) 122,500    
Exercisable at the end of the period (in shares) 80,834   45,000
Weighted Average Exercise Price      
Outstanding at the beginning of the period (in dollars per share) $ 25.73    
Granted (in dollars per share) 55.36    
Outstanding at the end of the period (in dollars per share) 29.36    
Exercisable at the end of the period (in dollars per share) $ 22.72   $ 20.32